Vanguard Group
VCNX

Vanguard Group’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Vanguard Group’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,444
Closed -$32.1K – 4496
2023
Q4 		$32.1K Hold
3,444
– – ﹤0.01% 4409
2023
Q3 		$54.5K Sell
3,444
-46
-1% -$2.34K ﹤0.01% 4402
2023
Q2 		$261K Hold
3,490
– – ﹤0.01% 4261
2023
Q1 		$293K Hold
3,490
– – ﹤0.01% 4258
2022
Q4 		$472K Buy
3,490
+3
+0.1% +$372 ﹤0.01% 4113
2022
Q3 		$363K Buy
3,487
+24
+0.7% +$4.71K ﹤0.01% 4301
2022
Q2 		$785K Hold
3,463
– – ﹤0.01% 4163
2022
Q1 		$960K Buy
3,463
+495
+17% +$137K ﹤0.01% 4220
2021
Q4 		$648K Hold
2,968
– – ﹤0.01% 4375
2021
Q3 		$1.35M Buy
2,968
+108
+4% +$53.9K ﹤0.01% 4174
2021
Q2 		$1.68M Buy
2,860
+1,697
+146% +$897K ﹤0.01% 4015
2021
Q1 		$728K Buy
1,163
+288
+33% +$185K ﹤0.01% 4069
2020
Q4 		$380K Buy
875
+197
+29% +$82.4K ﹤0.01% 4005
2020
Q3 		$253K Buy
678
+19
+3% +$20.7K ﹤0.01% 3929
2020
Q2 		$499K Hold
659
– – ﹤0.01% 3766
2020
Q1 		$553K Buy
659
+53
+9% +$60.1K ﹤0.01% 3652
2019
Q4 		$617K Buy
606
+1
+0.2% +$1.13K ﹤0.01% 3756
2019
Q3 		$912K Buy
605
+353
+140% +$397K ﹤0.01% 3675
2019
Q2 		$293K Buy
252
+2
+0.8% +$2.67K ﹤0.01% 3910
2019
Q1 		$276K Buy
250
+3
+1% +$2.88K ﹤0.01% 3867
2018
Q4 		$195K Buy
247
+12
+5% +$14.7K ﹤0.01% 3908
2018
Q3 		$341K Buy
+235
New +$485K ﹤0.01% 3916

Other funds holding VCNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Group's VCNX Position: Q1 2024 in Review

Vanguard Group sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 3,444 shares — an estimated $32.1K sold.

Vanguard Group first reported a position in VCNX in Q3 2018 and held it in 22 quarters. The position peaked at $1.68M in Q2 2021. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

  • Vanguard Group reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Vanguard Group sold 3,444 Vaccinex, Inc. Common Stock shares in Q1 2024, an estimated $32.1K.
  • Vanguard Group first reported a position in Vaccinex, Inc. Common Stock in Q3 2018 and held it in 22 quarters.
  • Vanguard Group's Vaccinex, Inc. Common Stock position peaked at $1.68M in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.